Miller Hugh R P, Pemberton Alan D
Department of Veterinary Clinical Studies, University of Edinburgh, Easter Bush Veterinary Centre, Roslin, Midlothian, UK.
Immunology. 2002 Apr;105(4):375-90. doi: 10.1046/j.1365-2567.2002.01375.x.
Serine proteinases with trypsin-like (tryptase) and chymotrypsin-like (chymase) properties are major constituents of mast cell granules. Several tetrameric tryptases with differing specificities have been characterized in humans, but only a single chymase. In other species there are larger families of chymases with distinct and narrow proteolytic specificities. Expression of chymases and tryptases varies between tissues. Human pulmonary and gastrointestinal mast cells express chymase at lower levels than tryptase, whereas rodent and ruminant gastrointestinal mast cells express uniquely mucosa-specific chymases. Local and systemic release of chymases and tryptases can be quantified by immunoassay, providing highly specific markers of mast cell activation. The expression and constitutive extracellular secretion of the mucosa-specific chymase, mouse mast cell proteinase-1 (mMCP-1), is regulated by transforming growth factor-beta1 (TGF-beta1) in vitro, but it is not clear how the differential expression of chymases and tryptases is regulated in other species. Few native inhibitors have been identified for tryptases but the tetramers dissociate into inactive subunits in the absence of heparin. Chymases are variably inhibited by plasma proteinase inhibitors and by secretory leucocyte protease inhibitor (SLPI) that is expressed in the airways. Tryptases and chymases promote vascular permeability via indirect and possibly direct mechanisms. They contribute to tissue remodelling through selective proteolysis of matrix proteins and through activation of proteinase-activated receptors and of matrix metalloproteinases. Chymase may modulate vascular tissues through its ability to process angiotensin-I to angiotensin-II. Mucosa-specific chymases promote epithelial permeability and are involved in the immune expulsion of intestinal nematodes. Importantly, granule proteinases released extracellularly contribute to the recruitment of inflammatory cells and may thus be involved in innate responses to infection.
具有胰蛋白酶样(类胰蛋白酶)和糜蛋白酶样(糜酶)特性的丝氨酸蛋白酶是肥大细胞颗粒的主要成分。在人类中已鉴定出几种具有不同特异性的四聚体类胰蛋白酶,但只有一种糜酶。在其他物种中,有更大的糜酶家族,其蛋白水解特异性独特且狭窄。糜酶和类胰蛋白酶的表达在不同组织间存在差异。人类肺和胃肠道肥大细胞中糜酶的表达水平低于类胰蛋白酶,而啮齿动物和反刍动物胃肠道肥大细胞则独特地表达黏膜特异性糜酶。糜酶和类胰蛋白酶的局部及全身释放可通过免疫测定进行定量,这为肥大细胞活化提供了高度特异性的标志物。黏膜特异性糜酶小鼠肥大细胞蛋白酶-1(mMCP-1)的表达和组成性细胞外分泌在体外受转化生长因子-β1(TGF-β1)调控,但尚不清楚在其他物种中糜酶和类胰蛋白酶的差异表达是如何调控的。已鉴定出的类胰蛋白酶天然抑制剂很少,但在没有肝素的情况下,四聚体会解离成无活性的亚基。糜酶受到血浆蛋白酶抑制剂和气道中表达的分泌性白细胞蛋白酶抑制剂(SLPI)的不同程度抑制。类胰蛋白酶和糜酶通过间接和可能的直接机制促进血管通透性。它们通过对基质蛋白的选择性蛋白水解以及通过蛋白酶激活受体和基质金属蛋白酶的激活来促进组织重塑。糜酶可能通过将血管紧张素-I加工成血管紧张素-II的能力来调节血管组织。黏膜特异性糜酶促进上皮通透性,并参与肠道线虫的免疫清除。重要的是,细胞外释放的颗粒蛋白酶有助于炎症细胞的募集,因此可能参与对感染的固有反应。